Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
12%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
12%
ALSO IN XPH
XPH
55
HOLDINGS
14%
ALSO IN XLV
SECTOR DRIFT (XLV minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
| MERCK & CO. INC. | 5.3% | 2.3% | 2.3% | |
| BRISTOL-MYERS SQUIBB CO | 2.2% | 2.2% | 2.2% | |
| JOHNSON & JOHNSON | 10.1% | 2.1% | 2.1% | |
| ELI LILLY & CO | 14.7% | 1.9% | 1.9% | |
| PFIZER INC | 2.7% | 1.9% | 1.9% | |
XLV Overweight Relative to XPH
| ELI LILLY & CO | 12.8% | |
| JOHNSON & JOHNSON | 8.0% | |
| ABBVIE INC | 6.9% | |
| UNITEDHEALTH GROUP INC | 4.4% | |
| AMGEN INC | 3.6% | |
| THERMO FISHER SCIENTIFIC INC | 3.6% | |
| ABBOTT LABORATORIES | 3.4% | |
| GILEAD SCIENCES INC | 3.3% | |
| INTUITIVE SURGICAL INC | 3.0% | |
| MERCK & CO. INC. | 3.0% |
XLV Underweight Relative to XPH
| DEFINIUM THERAPEUTICS INC | -2.5% | |
| LIQUIDIA TECHNOLOGIES, INC. | -2.4% | |
| PHIBRO ANIMAL HEALTH CORP-A | -2.3% | |
| EDGEWISE THERAPEUTICS, INC. | -2.2% | |
| AXSOME THERAPEUTICS, INC. | -2.2% | |
| AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.2% | |
| ELANCO ANIMAL HEALTH, INC. | -2.2% | |
| ROYALTY PHARMA PLC CLASS A | -2.1% | |
| ORGANON & CO. | -2.1% | |
| SUPERNUS PHARMACEUTICALS INC | -2.0% |